In this work, we have employed a previously developed microfluidic extravasation assay consisting of a self-organized 3D microvasculature that enables the study of tumor cell extravasation.
We describe a screening ELISA and a confirmation assay consisting of immune-purification followed by separation with SDS-PAGE and revelation with Western double blotting.
For that purpose, we designed a cell-free receptor binding assay consisting of a solid-phase recombinant soluble GM-CSF receptor α (GMRα) and a biotinylated GM-CSF (bGM-CSF).
Event specific primers targeting Roundup Ready Soybean (RRS, GTS40-3-2), A2704-12, DP356043-5, MON89788, A5547-127, and DP305423-1 were designed, and a multiplex PCR assay consisting of six event-specific fragments and one endogenous lectin fragment was developed.
Kinases were diluted in buffers of different composition, depending on the kinase assay, consisting of one or more of the following chemicals: MOPS, EDTA, Brij-35, Glycerol, NaCl, β-mercaptoethanol, BSA, HEPES, Triton X-100, DTT, Triton Surfactant, Glycerol, TRIS, EGTA, Tween 20, Na-β-glycerophosphate and Na3VO4.
The relevant parameters of the µFBI were optimized using an artificial capture assay consisting of an immobilized anti-biotin antibody and biotinylated PE as the analyte.
Each assay consisted of an allele-specific SuperSelective primer45 and a common primer shared by the normal and mutation assay.
Our assay consisted of 51 sets of primers designed to amplify all exons of these genes.
The assay consists of S1 nuclease protection, sandwich hybridization and signal detection.
The HRM assay consists of intercalating dye based real time quantitative PCR (qPCR) and melting curve analysis.
The assay consists of target-induced Ag+ dissociation from hairpin DNA and an isothermal circular strand-displacement polymerization (ICSDP) reaction.
